Company / Total Assets
Ovid Therapeutics Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$150.9M
FY2025
5-year range
$92.2M / $155.3M
FY2022-FY2025
Trend
+63.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $151M.
Based on SEC 10-K filings.
$151M in FY2025 with a 3-year CAGR of -0.9%.
Improved from $144M to $151M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -0.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -0.9%, indicating a declining trend.
- In FY2025, total assets increased 63.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $150.9M | +63.8% |
| FY2024 | $92.2M | -36.0% |
| FY2023 | $144.0M | -7.2% |
| FY2022 | $155.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026